Navigation Links
Worried Your Pet Will Get Lost or Stolen? Invest in Pet Identification
Date:4/7/2008

SACRAMENTO, Calif., April 7, 2008 /PRNewswire/ -- Many pet owners take their animals for granted thinking they'll always be at their side. But even the most loyal pets can wander, break loose or become victims of theft. Owners are left heartbroken knowing that if they had made a simple investment, there could be a chance of reuniting with their pet.

"We cannot stress enough the importance of pet identification to guard against the agony of losing a pet forever," said California Veterinary Medical Association (CVMA) President Jeff Smith, DVM. "Outfitting a pet with a collar and imprinted tag is a good first step, but inserting a microchip is the best means of permanent identification and significantly increases the likelihood of pets being reunited with their owners."

Studies show one in three pets will get lost during their lifetimes and without pet identification, 90 percent will not make it home. When Hurricane Katrina forced the evacuation of New Orleans, tens of thousands of pets were left behind, many with no identification tags. While the CVMA recommends collars and tags be worn at all times, they can easily slip off between the time the pet breaks out of the yard and ends up in a shelter.

With National Pet Identification Week being celebrated the third week in April, veterinarians, local SPCAs and humane societies are making a strong push to educate owners about the importance of microchipping and its long-term effectiveness in identifying animals and reuniting them with their owners.

"Many owners may be fearful of microchip implants, but it is a relatively painless procedure that will not affect a pet physically or behaviorally," added Dr. Smith.

Microchipping involves inserting an electronic capsule about the size of a grain of rice under the pet's skin. The chip is embedded with a unique alphanumeric identifier that contains information for contacting the relevant registry when scanned with an electronic reader. Pe
'/>"/>

SOURCE California Veterinary Medical Association
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. New Poll Shows Public Worried About Medicare Cuts Impact on Seniors, Boomers - Wants Congress To Act
2. Independent Voters Remain Worried about Health Care
3. Quest Diagnostics to Release First Quarter 2008 Financial Results and Conduct Quarterly Investor Conference Call
4. China Shenghuo Pharmaceutical Holdings, Inc. to Present at Brean Murray Carret & Co. Mainland China Investor Tour
5. Ilitch Charities Invests $50,000 in Innovative Community Programs
6. Simcere Pharmaceutical Group Announces Participation in Brean Murray Carret & Co.s Fourth Investor Tour of China
7. LodgeNet Interactive to Present at The B. Riley Investor Conference
8. Investigational anti-restenosis drug pimecrolimus disappoints
9. China Medicine Corporation to Present at Brean Murray Carret & Co. Mainland China Investor Tour
10. Flagship Global Health Will Host Investor Conference Call on Tuesday, April 1, 2008 at 1:15 PM EDT
11. Surgical Care Affiliates Announces Investor Conference Call to Discuss Fourth Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/8/2008)...aser scalpels, arthroscopic,surgery, genomic resea...rinary medicine is quickly expanding into new high...e benefit; it,s improving medicine for,people, too... care for their pets to,treat diseases like diabet... according to the American Veterinary Medical Asso...
(Date:9/8/2008)...zine examines Iraq and Afghanistan veterans, strug..., Washington, DC (PRWEB) S...by veterans of the Iraq and Afghanistan wars about... addiction disorders are featured in the current i...ublication of the National Council for Community B...
(Date:9/7/2008)...f older patients successfully treated for colorect...le to detect any recurrence of cancer. The study, ... , a peer-reviewed journal of the American Cancer ...monitoring of colorectal cancer survivors could af...y curative surgery for colorectal cancer have an i...
(Date:9/7/2008)... appear to lower a man,s PSA level, the blood biom...her a man is at risk of prostate cancer. , But t.... 8 in the journal Cancer , caution that men shou... prostate cancer just yet. , "We showed that me...rin and other non-steroidal anti-inflammatory drug...
Breaking Medicine News(10 mins):Health News:High-Tech Vet Medicine Saving Lives of Pets and People 2Health News:Helping Veterans in Our Communities 2Health News:Helping Veterans in Our Communities 3Health News:Many colorectal cancer survivors do not receive recommended follow-up care 2Health News:Common painkillers lower levels of prostate cancer biomarker 2
...min D supplements may help to reduce the risk of h...e 65 who took the supplements had nearly one-third... of certain forms of vitamin D have been associate....// But the positive impact of taking vitamin D su...
...rding to findings of a new report, the risks injec...tis C virus (HCV) from sharing commonly used drug ...ookers" and cotton filters.// While many anti-drug...of sharing hypodermic needles, the new study found...
...positive children ill with measles may get a tempo...ls of HIV are suppressed while measles infection r...findings, because we expected to see HIV replicati...liam Moss, who led the study, said. He said measle...
...ontin is a controlled substance in the United Stat... cancer patients and others. The pill is designed ..., to control the dosage of the powerful narcotic./... and sniffed, it gives a stronger dose--providing ...
Other Medicine News:Health News:Sharing injection equipment spreads Hepatitis C 2
(Date:9/4/2008)...tion for Targeted Therapies That Ensu...N BEACH, Calif., and AMSTERDAM, Netherlands, Sept....cular cancer diagnostics,today announced the laun...llows physicians to quantitatively determine the g...), progesterone receptor (PR) and Human Epidermal,...
(Date:9/3/2008)...irstCall/ -- Simcere,Pharmaceutical Group (NYSE: ...ded generic pharmaceuticals and manufacturer of th...known as Endostar) in China,announced the interim... request of the SFDA, Simcere initiated a Phase IV... therapeutic efficacy of Endu, a modified,version ...
(Date:9/3/2008)... /- Artelis SA and,Selexis SA announc...ntibody,production with the achievement of manufac...ord level was accomplished by applying two highly,...able Selexis CHO,production cell line rapidly gene... using their proprietary Selexis Genetic Elements(...
(Date:9/3/2008)...ingo Launch Progress and Adlea ...ence Call Today at 11:30 am ET, SOUTH SAN FRANCIS...iva,Inc. (Nasdaq: ANSV ) announced today that th...commercial and late-stage product development to,a...ical pain management,company. The company also pro...
Breaking Medicine Technology:Agendia Launches TargetPrint(R) for Breast Cancer Patients 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 3Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter 2Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter 3Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 2Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 3Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 4Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 5Iowa State researcher studies how enzymes break down cellulose 2066 1Iowa State researcher studies how enzymes break down cellulose 2066 2American College of Preventive Medicine calls on ABC to cancel Eli Stone episode 10551 1SAFC Pharma Expands Its Pharmorphix Solid State Chemistry Services 10547 1SAFC Pharma Expands Its Pharmorphix Solid State Chemistry Services 10547 2SAFC Pharma Expands Its Pharmorphix Solid State Chemistry Services 10547 3Drug Related Images Trigger Brains Reward Center 10545 1Drug Related Images Trigger Brains Reward Center 10545 2
...26, 2007 /PRNewswire-FirstCall/ --,Replidyne, Inc....,studying REP8839, a novel topical antibiotic that...skin pathogens including,methicillin-resistant S. ...how that topically applied REP8839 appears safe,w...osure, or drug,absorption into the bloodstream, wh...
...-Jun 25, 2007 - New data from an,investigational s...,(ADA) 67th Annual Scientific Sessions showed that...agliptin) and metformin,demonstrated significant i...ients with type 2 diabetes. Pancreatic islet beta,...o produce,insulin, a hormone which plays a central...
Other Medicine Technology:Replidyne Announces Positive Phase I Results for Topical Antibiotic,REP8839 2Replidyne Announces Positive Phase I Results for Topical Antibiotic,REP8839 3Replidyne Announces Positive Phase I Results for Topical Antibiotic,REP8839 4An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 2An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 3An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 4An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 5An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 6An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 7An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 8An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 9An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 10An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 11An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 12An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 13An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 14An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 15An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 16An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 17An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 18An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 19An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 20An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 21An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 22An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 23An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 24An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 25An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 26An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 27An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 28An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 29An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 30An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 31An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 32
The Explorer 360 and 360 Jr. catheters have a rotational connector for ease of use during procedures.
...of the PARAHISIAN catheter, combines an octapolar ...es, which permits the use of only one catheter for...is bundle electrograms. The "two catheters in one"...single venipuncture. The disadvantages of using tw...
Torqr Quadripolar Braided Shaft Fixed Curve. The Medtronic CardioRhythm Torqr Catheter is intended for use in diagnostic electrophysiologic procedures. The catheter is designed for recording intrac
Xtrem Dynamic is a line of steerable diagnosis catheters with micro handle. These catheters have been designed to provide pacing and recording during invasive electrophysiology procedures.
Medicine Products: